In vitro chondrogenesis and in vivo repair of osteochondral defect with human induced pluripotent stem cells

Biomaterials

Volumn 35, Issue 11, 2014, Pages 3571-3581

  Ko, Ji Yun ^a   Kim, Kyung Il ^a   Park, Siyeon ^a   Im, Gun Il ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Cartilage repair; Chondrogenic differentiation; Human iPS cells; Human mesenchymal stem cells

Indexed keywords

CARTILAGE REPAIR; CHONDROGENIC DIFFERENTIATION; HUMAN IPS CELLS; HUMAN MESENCHYMAL STEM CELLS;

ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; BONE AND BONES; BONE MARROW CELLS; CELL LINE; CELL SHAPE; CHONDROGENESIS; DNA METHYLATION; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HUMANS; HYPERTROPHY; INDUCED PLURIPOTENT STEM CELLS; MALE; MESENCHYMAL STROMAL CELLS; MESODERM; MOLECULAR SEQUENCE DATA; OSTEOGENESIS; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; WOUND HEALING;

EID: 84894995389     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.01.009     Document Type: Article

References (50)

1. Buckwalter J.A., Mankin H.J. Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 1988, 47:487-504.
2. Caplan A.I., Goldberg V.M. Principles of tissue engineered regeneration of skeletal tissues. Clin Orthop Relat Res 1999, 367:S12-S16.
3. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. NEngl J Med 1994, 331(14):889-895.
4. Benya P.D., Padilla S.R., Nimni M.E. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 1978, 15(4):1313-1321.
5. DeLise A.M., Fischer L., Tuan R.S. Cellular interactions and signaling in cartilage development. Osteoarthr Cartil 2000, 8(5):309-334.
6. Tuan R.S. Biology of developmental and regenerative skeletogenesis. Clin Orthop Relat Res 2004, 427:S105-S117.
7. Ingber D.E., Mow V.C., Butler D., Niklason L., Huard J., Mao J., et al. Tissue engineering and developmental biology: going biomimetic. Tissue Eng 2006, 12(12):3265-3283.
8. Goepfert C., Slobodianski A., Schilling A.F., Adamietz P., Pörtner R. Cartilage engineering from mesenchymal stem cells. Adv Biochem Eng Biotechnol 2010, 123:163-200.
9. Ichinose S., Tagami M., Muneta T., Sekiya I. Morphological examination during invitro cartilage formation by human mesenchymal stem cells. Cell Tissue Res 2005, 322(2):217-226.
10. Im G.I., Kim D.Y., Shin J.H., Hyun C.W., Cho W.H. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. JBone Joint Surg Br 2001, 83(2):289-294.
11. Kadiyala S., Young R.G., Thiede M.A., Bruder S.P. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential invivo and invitro. Cell Transplant 1997, 6(2):125-134.
12. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
13. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282(5391):1145-1147.
14. Lerou P.H., Daley G.Q. Therapeutic potential of embryonic stem cells. Blood Rev 2005, 19(6):321-331.
15. Gaspar-Maia A., Alajem A., Meshorer E., Ramalho-Santos M. Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol 2011, 12(1):36-47.
16. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
17. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
18. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., et al. Invitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448(7151):318-324.
19. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007, 1(1):39-49.
20. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858):1917-1920.
21. Itoh M., Kiuru M., Cairo M.S., Christiano A.M. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci U S A 2011, 108(21):8797-8802.
22. Lian Q., Zhang Y., Zhang J., Zhang H.K., Wu X., Zhang Y., et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010, 121(9):1113-1123.
23. Li F., Bronson S., Niyibizi C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. JCell Biochem 2010, 109(4):643-652.
24. Mizuno Y., Chang H., Umeda K., Niwa A., Iwasa T., Awaya T., et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 2010, 24(7):2245-2253.
25. Tashiro K., Inamura M., Kawabata K., Sakurai F., Yamanishi K., Hayakawa T., et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 2009, 27(8):1802-1811.
26. Taura D., Sone M., Homma K., Oyamada N., Takahashi K., Tamura N., et al. Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Arterioscler Thromb Vasc Biol 2009, 29(7):1100-1103.
27. Diekman B.O., Christoforou N., Willard V.P., Sun H., Sanchez-Adams J., Leong K.W., et al. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A 2012, 109(47):19172-19177.
28. Bilousova G., Jun du H., King K.B., De Langhe S., Chick W.S., Torchia E.C., et al. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both invitro and invivo. Stem Cells 2011, 29(2):206-216.
29. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4(6):472-476.
30. Xu C., Inokuma M.S., Denham J., Golds K., Kundu P., Gold J.D., et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001, 19(10):971-974.
31. Akopian V., Andrews P.W., Beil S., Benvenisty N., Brehm J., Christie M., et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. Vitro Cell Dev Biol Anim 2010, 46(3-4):247-258.
32. Li W., Zhou H., Abujarour R., Zhu S., Young Joo J., Lin T., et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009, 27(12):2992-3000.
33. Lee J.M., Im G.I. SOX trio-co-transduced adipose stem cells in fibrin gel to enhance cartilage repair and delay the progression of osteoarthritis in the rat. Biomaterials 2012, 33(7):2016-2024.
34. Kim H.J., Im G.I. The effects of ERK1/2 inhibitor on the chondrogenesis of bone marrow- and adipose tissue-derived multipotent mesenchymal stromal cells. Tissue Eng Part A 2010, 16(3):851-860.
35. Zimmermann P., Boeuf S., Dickhut A., Boehmer S., Olek S., Richter W. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum 2008, 58(9):2743-2753.
36. van den Borne M.P., Raijmakers N.J., Vanlauwe J., Victor J., de Jong S.N., Bellemans J., et al. International Cartilage Repair Society (ICRS) and Oswestry macroscopic cartilage evaluation scores validated for use in Autologous Chondrocyte Implantation (ACI) and microfracture. Osteoarthr Cartil 2007, 15(12):1397-1402.
37. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. JBone Joint Surg Am 1994, 76(4):574-592.
38. Toh W.S., Lee E.H., Guo X.M., Chan J.K., Yeow C.H., Choo A.B., et al. Cartilage repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived chondrogenic cells. Biomaterials 2010, 31(27):6968-6980.
39. Beier F.S., Vornehm E., Poschl K., von der Mark K., Lammi M.J. Localization of silencer and enhancer elements in the human type X collagen gene. JCell Biochem 1997, 66(2):210-218.
40. Fehrer C., Lepperdinger G. Mesenchymal stem cell aging. Exp Gerontol 2005, 40(12):926-930.
41. Stolzing A., Scutt A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell 2006, 5(3):213-224.
42. Solchaga L.A., Penick K., Goldberg V.M., Caplan A.I., Welter J.F. Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A 2010, 16(3):1009-1019.
43. Kim M.J., Son M.J., Son M.Y., Seol B., Kim J., Park J., et al. Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum 2011, 63(10):3010-3021.
44. Wei Y., Zeng W., Wan R., Wang J., Zhou Q., Qiu S., et al. Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cell Mater 2012, 12(23):1-12.
45. Medvedev S.P., Grigor'eva E.V., Shevchenko A.I., Malakhova A.A., Dementyeva E.V., Shilov A.A., et al. Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. Stem Cells Dev 2011, 20(6):1099-1112.
46. Teramura T., Onodera Y., Mihara T., Hosoi Y., Hamanishi C., Fukuda K. Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells. Cell Reprogr 2010, 12(3):249-261.
47. Hellingman C.A., Davidson E.N., Koevoet W., Vitters E.L., van den Berg W.B., van Osch G.J., et al. Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A 2011, 17(7-8):1157-1167.
48. Dickhut A., Pelttari K., Janicki P., Wagner W., Eckstein V., Egermann M., et al. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. JCell Physiol 2009, 219(1):219-226.
49. Pelttari K., Winter A., Steck E., Goetzke K., Hennig T., Ochs B.G., et al. Premature induction of hypertrophy during invitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion afterectopic transplantation in SCID mice. Arthritis Rheum 2006, 54(10):3254-3266.
50. Lee H.J., Lee J.S., Chansakul T., Yu C., Elisseeff J.H., Yu S.M. Collagen mimetic peptide-conjugated photopolymerizable PEG hydrogel. Biomaterials 2006, 27(30):5268-5276.